Autologous Stem Cell Rescue for Primary Amyloidosis
NCT00186407 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2010-09-14
Summary
To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis.
Conditions
- Amyloidosis
- Blood and Marrow Transplant (BMT)
Interventions
- PROCEDURE
-
high dose chemo then auto hematopoietic cell transplant
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Sally Arai · Stanford University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-04-30
- Primary Completion
- 2008-02-29
- Completion
- 2010-02-28
Countries
- United States
Study Locations
More Related Trials
-
Stem Cell Injection in Cancer Survivors
NCT02509156 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases.
NCT02943707 ·Status: UNKNOWN ·Phase: PHASE2
-
Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
NCT02504437 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke
NCT01501773 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure
NCT01502514 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction)
NCT01748383 ·Status: UNKNOWN ·Phase: PHASE2
-
Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction
NCT04421274 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure
NCT01709279 ·Status: UNKNOWN ·Phase: NA
-
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients
NCT00859014 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure
NCT01502501 ·Status: WITHDRAWN ·Phase: NA
-
Stem Cells for Treating Critical Ischemia
NCT00488020 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome
NCT01501461 ·Status: WITHDRAWN ·Phase: NA
-
Bone Marrow Stem Cell Infusion Following a Heart Attack
NCT00268307 ·Status: COMPLETED ·Phase: PHASE1
-
The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)
NCT00768066 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction
NCT01974128 ·Status: WITHDRAWN ·Phase: NA
-
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
NCT00535197 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy in Patients With Myocardial Infarction and Persistent Total Occlusion of Infarct Related Artery
NCT01625949 ·Status: UNKNOWN ·Phase: NA
-
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
NCT01297413 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction
NCT00874354 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
NCT06364150 ·Status: RECRUITING ·Phase: PHASE3
-
Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
NCT01297972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.
NCT00102128 ·Status: TERMINATED ·Phase: PHASE2
-
Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease
NCT03067857 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
NCT02467387 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI
NCT00626145 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2